Elanco Animal Health Inc. ELAN Business Segments — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Elanco Animal Health Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Elanco Animal Health Inc.'s business segments — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Elanco Animal Health Inc.'s business segments — revenue?
- Elanco Animal Health Inc. (ELAN) reported business segments — revenue of $1.37B in Q1 2026.
- How has Elanco Animal Health Inc.'s business segments — revenue changed year-over-year?
- Elanco Animal Health Inc.'s business segments — revenue increased by 14.9% year-over-year, from $1.19B to $1.37B.
- What is the long-term trend for Elanco Animal Health Inc.'s business segments — revenue?
- Over 3 years (2022 to 2025), Elanco Animal Health Inc.'s business segments — revenue has grown at a 2.2% compound annual growth rate (CAGR), from $4.41B to $4.72B.
- What does business segments — revenue mean?
- Total sales generated by the primary business segment.
- How do you interpret business segments — revenue?
- An increase indicates successful market penetration or higher product demand, while a decrease suggests competitive pressure or market contraction.
- How does business segments — revenue compare across companies?
- Standard revenue metric across all pharmaceutical and life sciences companies.